A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
scientific article published on 06 January 2020
Author/s
author: Emmanuelle Bompas, Axel Le Cesne, Isabelle Ray-Coquard, François Bertucci, Christine Chevreau, Jennifer Wallet, Corinne Delcambre, Sophie Taieb, Esma Saada-Bouzid, Loïc Chaigneau, Marie-Cécile Le Deley, Marie Vanseymortier, Olivier Mir, Sébastien Salas, Jean-Yves Blay, Emilie Decoupigny, Nicolas Penel
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.